Partners
In 2026, SAFE-ID receives unrestricted educational grants for the annual programme from the following partners:
Financial support 2026
- GSK: 20'000 CHF
- ViiV Healthcare: 75'000 CHF
- Gilead: 50'000 CHF
- MSD: 20'000 CHF
- Menarini: 5'000 CHF
All partners contribute to all educational events organised by SAFE-ID
Event Partner MSD is supporting the Challenge in Infectious Diseases.
Event Partner Menarini is supporting all SSI sessions.